Can isoniazid prevent TB in lupus patients?
Part of Immune system & allergy, Infections, Skin clinical trials.
This study tests if taking the TB prevention medicine isoniazid is safe for people with lupus (SLE). It may help protect you from getting tuberculosis while managing your lupus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lupus (SLE) and are currently in remission or have low to moderate disease activity.
- You do not have any signs of active TB and are not being treated for TB.
- You have never had TB, cancer, HIV, or abnormal liver function tests.
- You are not pregnant or breastfeeding and have no other active infections.
- You are willing to take isoniazid and join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests inhaled isoniazid (medicine) given through a nebulizer to see how well it works and how safe it is. It's for people being treated for tuberculosis.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests a medicine called Telitacicept to see if it can prevent lupus flares in people whose disease is currently mild or stable. It may be a good option if you want to keep your lupus under control and avoid sudden worsening.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study examines how different types of mycobacterial infections (including tuberculosis) affect your body's immune response. Researchers will compare immune function across different TB types and drug-resistance patterns to better understand the disease and improve treatment.
This trial tests whether a combination of two antiviral drugs, abacavir and lamivudine, can help people with lupus. It’s for patients whose lupus is not very active and who do not have certain infections or gene types that could cause side effects.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.